Clinical trial

Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer

NCT03628144

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2020-07-01

PhasePHASE2

Study timeline

Study start (estimated)2020-07-01Date precision: month

Registry last updated2020-09-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non Small Cell Lung Cancerunresolved

NSCLCunresolved

Non-small Cell Lung Cancerunresolved

Non-small Cell Lung Cancer Stage IIIBunresolved

Non-small Cell Lung Cancer Stage ⅢAunresolved

NSCLC Stage IIIBunresolved

NSCLC, Stage IIIAunresolved

Interventions

Impact® Advanced RecoveryDIETARY_SUPPLEMENT

Boost® High ProteinDIETARY_SUPPLEMENT

Radiation TherapyRADIATION

ChemotherapyDRUG

Quality of life (EORTC-QLQ-30)OTHER

Evaluation of Cognitive Function (FACT-Cog, v. 3.0)OTHER

Mindfulness Questionnaire (FFMQ)OTHER

Sponsors & collaborators

H. Lee Moffitt Cancer Center and Research Institutelead sponsor

Nestle Health Sciencecollaborator

Mapped research locations

TampaFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03628144 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.